![](https://www.microbiometimes.com/wp-content/uploads/2018/04/blur-1853262_960_720-326x245.jpg)
Finance
Synlogic Announces Registered Direct Offering of Common Stock
Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has agreed to sell 3,280,000 shares of its common stock to a large mutual […]